title: Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Couzin
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Kaiser
mesh_terms: D000293:Adolescent; D026683:Advisory Committees; D002986:Clinical Trials as Topic; D005602:France; D040181:Genetic Diseases, X-Linked / Q000628:therapy*; D015316:Genetic Therapy / Q000009:adverse effects* / Q000331:legislation & jurisprudence*; D006801:Humans; D007223:Infant; D007603:Jurisprudence; D007938:Leukemia / Q000209:etiology; D008297:Male; D009316:National Institutes of Health (U.S.); D016511:Severe Combined Immunodeficiency / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration